AAAAAA
Results:
1-19
|
Results: 19
Authors:
Mitsiades, N
Mitsiades, CS
Poulaki, V
Anderson, KC
Treon, SP
Citation: N. Mitsiades et al., Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma andother neoplasias, EXPERT OP I, 10(8), 2001, pp. 1521-1530
Authors:
Mitsiades, N
Poulaki, V
Mitsiades, CS
Anderson, KC
Citation: N. Mitsiades et al., Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors:new tricks from a (not so) old drug, EXPERT OP I, 10(6), 2001, pp. 1075-1084
Authors:
Mitsiades, N
Poulaki, V
Mitsiades, CS
Koutras, DA
Chrousos, GR
Citation: N. Mitsiades et al., Apoptosis induced FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases, TRENDS ENDO, 12(9), 2001, pp. 384-390
Authors:
Leone, A
Mitsiades, N
Ward, Y
Spinelli, B
Poulaki, V
Tsokos, M
Kelly, K
Citation: A. Leone et al., The Gem GTP-binding protein promotes morphological differentiation in neuroblastoma, ONCOGENE, 20(25), 2001, pp. 3217-3225
Authors:
Stechschulte, SU
Joussen, AM
von Recum, HA
Poulaki, V
Moromizato, Y
Yuan, J
D'Amato, RJ
Kuo, C
Adamis, AP
Citation: Su. Stechschulte et al., Rapid ocular angiogenic control via naked DNA delivery to cornea, INV OPHTH V, 42(9), 2001, pp. 1975-1979
Authors:
Joussen, AM
Huang, S
Poulaki, V
Camphausen, K
Beecken, WD
Kirchhof, B
Adamis, AP
Citation: Am. Joussen et al., In vivo retinal gene expression in early diabetes, INV OPHTH V, 42(12), 2001, pp. 3047-3057
Authors:
Joussen, AM
Beecken, WD
Moromizato, Y
Schwartz, A
Kirchhof, B
Poulaki, V
Citation: Am. Joussen et al., Inhibition of inflammatory corneal angiogenesis by TNP-470, INV OPHTH V, 42(11), 2001, pp. 2510-2516
Authors:
Poulaki, V
Mitsiades, N
Mastorakos, G
Caspi, RR
Chrousos, GP
Bouzas, E
Citation: V. Poulaki et al., Fas/Fas Ligand-associated apoptosis in experimental autoimmune uveoretinitis in rodents: Role of proinflammatory corticotropin-releasing hormone, EXP EYE RES, 72(6), 2001, pp. 623-629
Authors:
Mitsiades, N
Poulaki, V
Mitsiades, C
Tsokos, M
Citation: N. Mitsiades et al., Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5, CANCER RES, 61(6), 2001, pp. 2704-2712
Authors:
Mitsiades, N
Yu, WH
Poulaki, V
Tsokos, M
Stamenkovic, I
Citation: N. Mitsiades et al., Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity, CANCER RES, 61(2), 2001, pp. 577-581
Authors:
Poulaki, V
Mitsiades, N
Romero, ME
Tsokos, M
Citation: V. Poulaki et al., Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and bcl-2, CANCER RES, 61(12), 2001, pp. 4864-4872
Authors:
Schwesinger, C
Yee, C
Rohan, RM
Joussen, AM
Fernandez, A
Meyer, TN
Poulaki, V
Ma, JJK
Redmond, TM
Liu, SY
Adamis, AP
D'Amato, RJ
Citation: C. Schwesinger et al., Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium, AM J PATH, 158(3), 2001, pp. 1161-1172
Authors:
Mitsiades, N
Poulaki, V
Tseleni-Balafouta, S
Chrousos, GP
Koutras, DA
Citation: N. Mitsiades et al., Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease, THYROID, 10(7), 2000, pp. 527-532
Authors:
Mitsiades, N
Poulaki, V
Tseleni-Balafouta, S
Koutras, DA
Stamenkovic, I
Citation: N. Mitsiades et al., Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand, CANCER RES, 60(15), 2000, pp. 4122-4129
Authors:
Mitsiades, N
Poulaki, V
Leone, A
Tsokos, M
Citation: N. Mitsiades et al., Fas-mediated apoptosis in Ewing's sarcoma cell lines by metalloproteinase inhibitors, J NAT CANC, 91(19), 1999, pp. 1678-1684
Authors:
Poulaki, V
Benekou, A
Bozas, E
Bolaris, S
Stylianopoulou, F
Citation: V. Poulaki et al., P53 expression and regulation by NMDA receptors in the developing rat brain, J NEUROSC R, 56(4), 1999, pp. 427-440
Authors:
Mitsiades, N
Poulaki, V
Mastorakos, G
Tseleni-Balafouta, S
Kotoula, V
Koutras, DA
Tsokos, M
Citation: N. Mitsiades et al., Fas ligand expression in thyroid carcinomas: A potential mechanism of immune evasion, J CLIN END, 84(8), 1999, pp. 2924-2932
Authors:
Butler, AA
Blakesley, VA
Tsokos, M
Poulaki, V
Wood, TL
LeRoith, D
Citation: Aa. Butler et al., Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression (vol 58, pg 3021, 1998), CANCER RES, 58(23), 1998, pp. 5630-5630
Authors:
Mitsiades, N
Poulaki, V
Kotoula, V
Leone, A
Tsokos, M
Citation: N. Mitsiades et al., Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase, AM J PATH, 153(6), 1998, pp. 1947-1956
Risultati:
1-19
|